Ledger.Open graph →
SEC Form D · filed March 22, 2023

Lucid Diagnostics Inc

Offering
$20.0M
Sold
$13.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Debra M. White · New York, NYDirectorShaun M. O'Neil · New York, NYExecRonald M. Sparks · New York, NYDirectorMichael A. Gordon · New York, NYExecLishan Aklog · New York, NYExec · DirectorJames L. Cox · New York, NYDirectorDennis M. Mcgrath · New York, NYExecStanley L. Lapidus · New York, NYDirectorJacque J. Sokolov · New York, NYDirectorPat S. Loret De Mola · Wainscott, NYDirectorPete Koziol · Provo, UTDirectorScott Robertson · Provo, UTExecJason C. Karnowski · Hermantown, MNDirectorJonathan M. Taylor · Maitland, FLExecMichael S. Williams · Chatham, NJExecMike Ferrari · Provo, UTDirectorAdam M. Meyers · Long Beach Township, NJExec · DirectorJoseph S. Colaprico · Nokomis, FLDirectorCaleb Edwards · Grandview, MOExecVinod Nagi · Cedar Park, TXDirectorMarcus N. Steele · CARDIFF, CADirectorDavid N. Stefanick · CARDIFF, CAExecChris Nero · CARDIFF, CAExec · DirectorGeorge T. Ermel · Weston, FLDirectorRobert Nagele · Stratford, NJDirectorRene Chaze · Stratford, NJExecSanjay Chandra · Southlake, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗